Low-Dose Ibuprofen in Improving Cognitive Impairment in Patients With Cancer

Completed · Phase 2 · Has a placebo group

Conditions studied: Cognitive Impairment, Malignant Neoplasm

In brief

This randomized phase II trial studies how well low-dose ibuprofen in improving cognitive impairment in patients with cancer. Anti-inflammatory agents, such as ibuprofen, may slow the decline of cognitive processes and diseases involving the brain.

Key facts

Study ID
NCT03186638
Run by
University of Rochester NCORP Research Base
People needed
87
Starts
2017-05-26
Expected to finish
2022-06-01
Last updated by the study team
2023-09-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.